Skip to main content

BANK OF AMERICA CORP /DE/

Bank

Position in ESPR — Esperion Therapeutics, Inc.

CIK 70858 CHARLOTTE, NC

Position in ESPR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
450,625
+80.7% QoQ
Ownership
0.175%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Derivatives in ESPR

reported options exposure · as of Dec 31, 2021
CallValue
$0
CallShares
0
PutValue
$0
PutShares
16,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $1,596,028,663 across 49 Drug Manufacturers - Specialty & Generic names. ESPR ranks #49 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 450,625
2026-03-31 249,395
2025-12-31 696,790
2025-09-30 304,572
2025-06-30 836,339
2025-03-31 1,527,263
2024-12-31 1,629,980
2024-09-30 1,123,552
2024-06-30 1,163,424
2024-03-31 4,545,260
2023-12-31 176,536
2023-09-30 104,505
2023-06-30 184,121
2023-03-31 513,199
2022-12-31 87,495
2022-09-30 65,766
2022-06-30 74,592
2022-03-31 88,413
2021-12-31 16,700
2021-12-31 138,753
2021-09-30 77,148
2021-09-30 24,300
2021-06-30 26,128
2021-03-31 39,357
2020-12-31 37,266
2020-09-30 39,249
2020-06-30 34,758
2020-03-31 23,561